Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2Gastrointestinal 2Tumor-Agnostic 1Thoracic 1Plasma cell 1Myeloid 1Head & Neck 1Gynecologic 1Dermatologic 1Breast 1

Conditions

Uterine Cervical Neoplasms 1Behavior 1

Interventions

Paclitaxel 268Carboplatin 264Cisplatin 194Bevacizumab 135pembrolizumab 99Surveys and Questionnaires 84Radiotherapy 77Cyclophosphamide 75olaparib 67Blood Specimen Collection 65Drug Therapy 62Hyperthermic Intraperitoneal Chemotherapy 60Gemcitabine 60niraparib 56Topotecan 56Brachytherapy 54liposomal doxorubicin 52Taxes 47Docetaxel 46Magnetic Resonance Spectroscopy 43Letrozole 36Cytoreduction Surgical Procedures 36Filgrastim 33Biopsy 33Surgical Procedures, Operative 32durvalumab 31Specimen Handling 31Doxorubicin 31Nivolumab 30Albumin-Bound Paclitaxel 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × House Calls × Gynecologic × Clear all
NCT03076879 2019-09-18

Increasing Participation in Cervical Cancer Screening and Risk for Beliefs/Attitudes Among Women at Risk

Selcuk University

Phase NA Completed
114 enrolled
Gynecologic

Behavior, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡